Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study
Okan Oktar,Vakkas Korkmaz,Alp Tokalıoğlu,Çağatayhan Öztürk,Özgür Erdoğan,Yeşim Uçar,Hande Esra Koca Yıldırım,Candost Hanedan,Fatih Kılıç,Burak Ersak,Necim Yalçın,Fatma Özmen,Alper Kahraman,Selin Aktürk Esen,Sevda Baş,Emel Doğan Özdaş,İlker Selçuk,Gökhan Uçar,Özgür Koçak,Caner Çakır,Sevgi Koç,Çiğdem Kılıç,Günsu Kimyon Cömert,Işın Üreyen,Tayfun Toptaş,Mehmet Ali Narin,Tolga Taşçı,Salih Taşkın,Nurettin Boran,Muzaffer Sancı,Fahriye Tuğba Köş,Özlem Moraloğlu Tekin,Yaprak Engin Üstün,Fırat Ortaç,Taner Turan
DOI: https://doi.org/10.3802/jgo.2024.35.e39
Abstract:Objective: To define the clinical, histopathological features and the prognostic factors affecting survival in patients with adult granulosa cell tumors of the ovary (AGCT). Methods: A 322 patients whose final pathologic outcome was AGCT treated at nine tertiary oncology centers between 1988 and 2021 participated in the study. Results: The mean age of the patients was 51.3±11.8 years and ranged from 21 to 82 years. According to the International Federation of Gynecology and Obstetrics 2014, 250 (77.6%) patients were stage I, 24 (7.5%) patients were stage II, 20 (6.2%) patients were stage III, and 3 (7.8%) were stage IV. Lymphadenectomy was added to the surgical procedure in 210 (65.2%) patients. Lymph node involvement was noted in seven (3.3%) patients. Peritoneal cytology was positive in 19 (5.9%) patients, and 13 (4%) had metastases in the omentum. Of 285 patients who underwent hysterectomy, 19 (6.7%) had complex hyperplasia with atypia/endometrial intraepithelial neoplasia, and 8 (2.8%) had grade 1 endometrioid endometrial carcinoma. It was found that 93 (28.9%) patients in the study group received adjuvant treatment. Bleomycin, etoposide, cisplatin was the most commonly used chemotherapy protocol. The median follow-up time of the study group was 41 months (range, 1-276 months). It was noted that 34 (10.6%) patients relapsed during this period, and 9 (2.8%) patients died because of the disease. The entire cohort had a 5-year disease-free survival (DFS) of 86% and a 5-year disease-specific survival of 98%. Recurrences were observed only in the pelvis in 13 patients and the extra-abdominal region in 7 patients. The recurrence rate increased 6.168-fold in patients with positive peritoneal cytology (95% confidence interval [CI]=1.914-19.878; p=0.002), 3.755-fold in stage II-IV (95% CI=1.275-11.063; p=0.016), and 2.517-fold in postmenopausal women (95% CI=1.017-6.233; p=0.046) increased. Conclusion: In this study, lymph node involvement was detected in 3.3% of patients with AGCT. Therefore, it was concluded that lymphadenectomy can be avoided in primary surgical treatment. Positive peritoneal cytology, stage, and menopausal status were independent prognostic predictors of DFS.